Which jwh is still legal

Before making a finding that temporarily placing a substance into Schedule I of the CSA is necessary to avoid an imminent hazard to the public safety, the Administrator must consider three of the eight factors factors 4, 5, and 6 set forth in section c of the CSA 21 U.

These factors are the history and current pattern of abuse, the scope, duration, and significance of abuse, and what, if any, risk there is to the public health, including actual abuse, diversion from legitimate channels, and clandestine importation, manufacture, or distribution. The temporary placement of these five synthetic cannabinoids into Schedule I of the CSA is necessary in order to avoid an imminent hazard to the public safety.

First, these substances are not intended for human consumption, but there has been a rapid and significant increase in abuse of these substances in the United States. As a result of this abuse, synthetic cannabinoids are banned in at least 18 states in the United States and several countries, and all five branches of the U. Second, law enforcement has seized synthetic cannabinoids in conjunction with controlled substances and based on self-reports to law enforcement and health care professionals, synthetic cannabinoids are abused for their psychoactive properties.

Third, numerous state and local public health departments and poison control centers have issued health warnings describing the adverse health effects associated with synthetic cannabinoids. Based on scientific data currently available, these five substances have the potential to be extremely harmful and, therefore, pose an imminent hazard to the public safety.

A "cannabinoid" is a class of chemical compounds in the marijuana plant that are structurally related. The cannabinoid [Delta]9- tetrahydrocannabinol THC is the primary psychoactive constituent of marijuana. Two of the five synthetic cannabinoids CP, and cannabicyclohexanol were synthesized in the early s for research purposes. JWH, JWH, and JWH were prepared in the mids and evaluated to further advance understanding of drug-receptor interactions regarding the cannabinoid system.

Developed and evaluated as research tools, no other known legitimate uses have been identified for these five synthetic cannabinoids. Furthermore, these five synthetic cannabinoids are not intended for human consumption.

The emergence of these five synthetic cannabinoids represents a recent phenomenon in the U. Since the initial identification of JWH by U. These synthetic cannabinoids have purported psychotropic effects when smoked or ingested.

These substances are typically found in powder form or are dissolved in appropriate solvents, such as acetone, before being sprayed on the plant material contained in the herbal incense products. The popularity of these THC-like synthetic cannabinoids has significantly increased throughout the United States, and they are being abused for their psychoactive properties as reported by law enforcement, the medical community, and through scientific literature.

Some of the product names include, but are not limited to, "Spice," "K2," and many more. Due to sophisticated marketing, the products that contain these five THC-like synthetic cannabinoids are perceived as "legal" alternatives to marijuana despite the fact that they are typically advertised as herbal incense or plant food Bonsai- 18 by Internet retailers, tobacco shops, head shops, and other domestic brick and mortar retail venues, and labeled "Not For Human Consumption.

Based on law enforcement encounters, these five substances are typically found laced on plant material. The plant material is packaged in small pouches or packets, and is being sold over the Internet, in tobacco and smoke shops, drug paraphernalia shops, gas stations, and convenience stores as herbal incense products, giving customers of all ages direct access to these five substances.

The most common route of administration of these synthetic cannabinoids is by smoking using a pipe, a water pipe, or rolling the drug-spiked plant material in cigarette papers. These five synthetic cannabinoids alone or spiked on plant material have the potential to be extremely harmful due to their method of manufacture and high pharmacological potency. There is little information regarding the pharmacology, toxicology, and safety of these substances in humans given the minimal amount of pre-clinical investigations undertaken regarding these substances; therefore, the full danger of these drugs has not yet been determined.

As of January 31, , 18 states in the United States and other countries have controlled one or more of the five synthetic cannabinoids. Moreover, all five branches of the military prohibit their personnel from possessing or using synthetic cannabinoids associated with products such as Spice and K2.

According to forensic laboratory reports, the initial appearance of these synthetic cannabinoids in herbal incense products in the United States occurred in November when U. J Mass Spectrom —7. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

J Mass Spectrom — Springfield, VA: U. Drug Enforcement Administration Google Scholar. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther — PubMed Abstract Google Scholar. Drug Alcohol Depend — Differential drug-drug interactions of the synthetic cannabinoids JWH and JWH implications for drug abuse liability and pain therapy.

Behav Pharmacol —7. Cross-substitution of delta9-tetrahydrocannabinol and JWH in drug discrimination in rats. Pharmacol Biochem Behav —8. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

Schizophr Bull — The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. Psychol Med — Hamilton I. Cannabis, psychosis and schizophrenia: unravelling a complex interaction. Addiction 9 —7. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry — Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry —8.

Biol Psychiatry — A proposed pathological model in the hippocampus of subjects with schizophrenia. Clin Exp Pharmacol Physiol —3. Darmani NA. Pharmacol Biochem Behav —7. Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment.

Int J Neuropsychopharmacol — Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats. Neurosci Lett —9. Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors.

PLoS Biol e Br J Pharmacol — Pranzatelli MR. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1- 2,5-dimethoxyiodophenyl aminopropane Neurosci Lett — Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxyiodophenyl]aminopropane.

Prog Neuropsychopharmacol Biol Psychiatry — Eur J Pharmacol — The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy di-n-propylamino tetralin in the rat.

Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. J Psychopharmacol — Fattore L. Synthetic cannabinoids-further evidence supporting the relationship between cannabinoids and ssychosis. Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT 2A and dopamine D 2 receptors in rat prefrontal cortex. G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.

J Biol Chem — The cannabinoid agonist HU pseudo-irreversible discriminative stimulus effects in rhesus monkeys. One of the main causes of these incidents is the rise in consumption and popularity of synthetic cannabis. But what is this substance and how did its formation take place? In , an organic chemist called John Huffmann and his colleagues at Clemson University in South Carolina published their research, into new ways of developing anti-inflammatory drugs, which by chance happened to involve the creation of hundreds of synthetic cannabis compounds, including one called JWH When scientists decided to test this newly formed substance, they quickly discovered that it had no connection to the cannabis plant, but instead contained the newly discovered compound JWH created by Huffman and his peers.

In order to find alternative methods of consuming the substance chemists started making Spice with other synthetic compounds of which there are over that were still legal, meaning new substances were hitting the market on a daily basis. These new variations in the substance have fallen into the hands of users over the world including the UK, despite the ban being placed to try and curb the effects of the legal high. Furthermore, prisons across the UK are experiencing increasing cases of prisoners smuggling in and using the substance.

They then suffer from varying range of effects depending on the potency. Nigel Newcomen, who investigates every death in custody, said there was 39 deaths linked to new psychoactive substances, such as the synthetic cannabinoid Spice, a rise from the figure of 19 between and There are numerous cases worldwide where Spice has left people with horrible effects due to developing addiction to the substance quickly.

Some people have pointed to the potency of the drug as to one of the reasons for addiction. Hermanns-Clausen, M. Drug Test. Hlozek, T. Horsley, R. Psychiatry Detailed pharmacological evaluation of methoxetamine MXE , a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.

Brain Res Bull. Huffman, J. Structure-activity relationships for 1-alkyl 1-naphthoyl indoles at the cannabinoid CB 1 and CB 2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB 2 receptor agonists. Kevin, R. Kucerova, J. Therapeutic potential of cannabinoids in schizophrenia. Recent Pat. Drug Discov. Leighty, E. Metabolism and distribution of cannabinoids in rats after different methods of administration.

PubMed Abstract Google Scholar. Levin, R. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Long, L. A follow-up study: acute behavioural effects of Delta 9 -THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Malone, D. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Brain Res. Malyshevskaya, O. Marshell, R. Micale, V. Endocannabinoid system and mood disorders: priming a target for new therapies.

Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res. Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus. Moreira, F. Cannabinoids and anxiety. Ossato, A. Psychiatry 67, 31— Palenicek, T. Emerging toxicity of 5,6-methylenedioxyaminoindane MDAI : pharmacokinetics, behaviour, thermoregulation and LD50 in rats.

Psychiatry 69, 49— Papanti, D. Patel, S. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. Rey, A. Neuropsychopharmacology 37, — Rubino, T. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cortex 18, — Schaefer, N.

Schneir, A.